Eric Halioua is CEO at Promethera Biosciences, a biotechnology company that discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way. He was also a Board Member of a French biotechnology company called Vivalis, which specializes in the production of avian stem cells lines for the production of vaccines and recombinant proteins.
Corporate strategy, marketing, business development and licensing-in/out, founder of biotechnology companies